AINC vs. LICN, NOM, CUBA, OPHC, EFBI, PPSF, HMG, MCVT, WVFC, and FPAY
Should you be buying Ashford stock or one of its competitors? The main competitors of Ashford include Lichen China (LICN), Nuveen Missouri Quality Municipal Income Fund (NOM), The Herzfeld Caribbean Basin Fund (CUBA), OptimumBank (OPHC), Eagle Financial Bancorp (EFBI), Peoples-Sidney Financial (PPSF), HMG/Courtland Properties (HMG), Mill City Ventures III (MCVT), WVS Financial (WVFC), and FlexShopper (FPAY). These companies are all part of the "finance" sector.
Ashford vs.
Lichen China (NASDAQ:LICN) and Ashford (NYSEAMERICAN:AINC) are both small-cap finance companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, community ranking, media sentiment, institutional ownership and valuation.
In the previous week, Lichen China had 1 more articles in the media than Ashford. MarketBeat recorded 2 mentions for Lichen China and 1 mentions for Ashford. Ashford's average media sentiment score of 0.34 beat Lichen China's score of 0.00 indicating that Lichen China is being referred to more favorably in the media.
0.2% of Lichen China shares are owned by institutional investors. Comparatively, 13.0% of Ashford shares are owned by institutional investors. 66.7% of Ashford shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Ashford has a net margin of 0.01% compared to Ashford's net margin of 0.00%. Ashford's return on equity of 0.00% beat Lichen China's return on equity.
Ashford has a consensus price target of $13.50, suggesting a potential upside of 105.48%. Given Lichen China's higher possible upside, analysts plainly believe Ashford is more favorable than Lichen China.
Lichen China has higher earnings, but lower revenue than Ashford.
Ashford received 143 more outperform votes than Lichen China when rated by MarketBeat users.
Summary
Ashford beats Lichen China on 8 of the 13 factors compared between the two stocks.
Get Ashford News Delivered to You Automatically
Sign up to receive the latest news and ratings for AINC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartMedia Sentiment Over Time
This chart shows the average media sentiment of NYSEAMERICAN and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Related Companies and Tools